Editas Medicine (NASDAQ:EDIT) on Friday announced initial safety and efficacy data from a pair of trials designed to evaluate EDIT-301, a gene editing candidate targeted at inherited blood disorders, ...

Change is never easy. We often resist it even when we know it can lead to positive outcomes. Journalist and author Sydney J. Harris summed up our awkward relationship with change when he stated, “Our ...

Tableau is a data visualization tool that helps users create charts, graphs, maps and dashboards for visualizing and analyzing data. It provides a platform for understanding data, and for sharing ...